<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>inhaled nitric oxide therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/inhaled-nitric-oxide-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 20 Oct 2025 08:51:26 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>inhaled nitric oxide therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Rethinking Inhaled Nitric Oxide: Lung to Eye Protection</title>
		<link>https://bioengineer.org/rethinking-inhaled-nitric-oxide-lung-to-eye-protection/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 20 Oct 2025 08:51:01 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[inhaled nitric oxide therapy]]></category>
		<category><![CDATA[neonatal systemic vascular disorders]]></category>
		<category><![CDATA[ocular complications in preterm infants]]></category>
		<category><![CDATA[persistent pulmonary hypertension of the newborn]]></category>
		<category><![CDATA[Retinopathy of Prematurity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/rethinking-inhaled-nitric-oxide-lung-to-eye-protection/</guid>

					<description><![CDATA[In the realm of neonatal care, persistent pulmonary hypertension of the newborn (PPHN) poses a formidable challenge, traditionally viewed as a localized pulmonary disorder affecting primarily the lungs. However, recent groundbreaking studies are reshaping our understanding of this condition, revealing intricate links that extend beyond the pulmonary system and implicate systemic vascular vulnerabilities. Notably, emerging [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">283604</post-id>	</item>
	</channel>
</rss>
